[The differentiation of human gastric adenocarcinoma cell line MGc80-3 induced by dibutyryl cAMP in vitro].
For providing some experimental basis in establishing malignant phenotypic reversed indexes of gastric carcinoma cells, human gastric adenocarcinoma cell line MGc-80-3 was induced by dBcAMP in vitro to appraise the effect of gastric carcinoma cell differentiation by chemical inducers. Under light microscope, MGc 80-3 cells, after treated with 1 mM dBcAMP, tended to be flat and disperse, and their volume gradually enlarged, with their nucleus relatively smaller and their shape rather regular. Morphological changes, became like normal differentiated epithelial cells, were observed. The cells attached firmly, grew slowly, their growth curve showed inhibitory rate amounted to 52.87%, and cellular division exponent displayed their peak value 1.5 times less than that of MGc 80-3 cells. It was clear that dBcAMP could effectively inhibit the multiplication activity of MGc-80-3 cells. In the cells after dBcAMP treatment, remarkable changes of cell surface charges was indicated by cell electrophoresis, the ratio dropped to 3.043 from 3.988, and their retardant ratio reached up to 31.2%. cAMP content in cells after this treatment, detected by cAMP and cGMP radioimmunoassay, was enhanced by 2.42 times; and cAMP/cGMP ratio, by 1.73 times. Thus, cAMP level within MGc 80-3 cells was raised obviously by dBcAMP. Heterotransplantation experiments showed that tumoriferous rate of MGc 80-3 cells (transplanted subcutaneously to BABL/c mice) amounted to 100%, and that of the cells after this treatment was only 5.6%. Their tumorigenic ability was extremely reduced. These results fully confirmed that dBcAMP was able to change MGc 80-3 cell's malignant phenotypic characteristics and produce a reversed alteration; thus, it has a remarkable inductive effect in differentiating gastric carcinoma cells.(ABSTRACT TRUNCATED AT 250 WORDS)
Li
Q F
QF
Laboratory of Cell Biology, Xiamen University.
Wang
D Y
DY
D000230:Adenocarcinoma / Q000473:pathology*; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology*; D002454:Cell Differentiation / Q000187:drug effects; D000242:Cyclic AMP / Q000032:analysis; D006152:Cyclic GMP / Q000032:analysis; D006801:Humans; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009368:Neoplasm Transplantation; D013274:Stomach Neoplasms / Q000473:pathology*; D014407:Tumor Cells, Cultured / Q000187:drug effects
D003994:Bucladesine; D000242:Cyclic AMP; D006152:Cyclic GMP